Skip to content
10-K

Annual Report

CORE LABORATORIES INC. CLB

0000950170-25-019072

← back to feed
Filed
Feb 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jan 31, 2025 46.83M sh
Long Term Debt FY 2024 · Dec 31, 2023 $163.13M
Cash And Equivalents FY 2024 · Dec 31, 2023 $15.12M
Stockholders Equity FY 2024 · Dec 31, 2023 $224.82M
Current Liabilities FY 2024 · Dec 31, 2023 $88.1M
Current Assets FY 2024 · Dec 31, 2023 $223.14M
Shares Diluted FY 2024 · Dec 31, 2022 46.81M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $3.9M
Dividends Paid FY 2024 · Dec 31, 2022 $1.85M
Capex FY 2024 · Dec 31, 2022 $10.22M
Operating Cash Flow FY 2024 · Dec 31, 2022 $24.96M
Total Assets FY 2024 · Dec 31, 2022 $578.35M
Eps Diluted FY 2024 · Dec 31, 2022 $0.42
Eps Basic FY 2024 · Dec 31, 2022 $0.42
Sga Expense FY 2024 · Dec 31, 2022 $38.12M
Net Income FY 2024 · Dec 31, 2022 $19.45M
Operating Income FY 2024 · Dec 31, 2022 $41.52M
Cost Of Revenue FY 2024 · Dec 31, 2022 $393.66M
Revenue FY 2024 · Dec 31, 2022 $489.74M